BigHat Biosciences
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
$75MSeries C
LeadActivity from announced rounds
An AI and synthetic-biology platform that designs and engineers antibody therapeutics.
Builds highly maneuverable orbital transfer vehicles and kick stages for in-space mobility and satellite logistics